Noleus Technologies Inc. news
Swarna Balasubramaniam, MD, spoke at last night`s MDG Boston event "MedTech Leaders Share Insights from Product Development Journeys", an event that shared perspectives ranging from start-ups nearing commercialization to large global organizations with game-changing product portfolios.
Specific medtech challenges covered include improved preservation of donor organs in transport, treatment of postoperative intestinal blockage, and strategies used
Noleus applied for the competitive StartX Med process to work alongside entrepreneurs in the StartX program, which is focused on accelerating the development of Stanford`s top medical entrepreneurs through experiential education and collective intelligence. The program focuses on adva
MassChallenge, a global network of zero-equity startup accelerators, last night named three prize winners from its first Houston-based program: NeuroRescue, Noleous Technologies, and Sensytech. Announced at the MassChallenge Texas in Houston Finale at the House of Blues Houston, this news caps off the first-ever MassChallenge Texas in Houston program, which accelerated 25 of the world’s highest potential, early-stage startups.
“It took a city-wide effort to bring
Noleus Technologies advanced to the Semi-Finals of the Rice Business Plan Competition, finishing in the top third of the 42 competitors.
Noleus shared our technology and business plan in a 15 minute pitch to investors and judges followed by 10-20 minutes of Question & Answer sessions. We expanded our network with the teams, judges, and investors present.
About the Rice Business Plan Competition
The Rice
Noleus Technologies won the audience choice award at the MedTech Innovator Houston Pitch Event. The event was hosted at the Johnson and Johnson Innovation JLABS@TMC event space.
According to the MedTech Innovator website, these events "feature pitches from best-in-class medical device, diagnostic, and digital health companies vying for a spot in the 2018 program."
Judging from local experts in the life sciences and medical device community will